Sessa Capital IM, L.P.'s Net Worth

$265 Million

Estimate Recalculated Jul 17, 2024 03:32PM EST

Who is Sessa Capital IM, L.P.?

Sessa Capital IM, L.P. has an estimated net worth of $265 Million. This is based on reported shares across multiple companies, which include COMPX INTERNATIONAL INC, Garrett Motion Inc., Provention Bio, Inc., and SAB Biotherapeutics, Inc..

SEC CIK

Sessa Capital IM, L.P.'s CIK is 0001595849

Past Insider Trading and Trends

2023 was Sessa Capital IM, L.P.'s most active year for acquiring shares with 11 total transactions. Sessa Capital IM, L.P.'s most active month to acquire stocks was the month of October. 2023 was Sessa Capital IM, L.P.'s most active year for disposing of shares, totalling 12 transactions. Sessa Capital IM, L.P.'s most active month to dispose stocks was the month of March. 2023 saw Sessa Capital IM, L.P. paying a total of $124,461,138.00 for 31,903,291 shares, this is the most they've acquired in one year. In 2023 Sessa Capital IM, L.P. cashed out on 49,935,842 shares for a total of $112,743,151.68, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

COMPX INTERNATIONAL INC (CIX) Snapshot price: $24.12

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Garrett Motion Inc. (GTX) Snapshot price: $8.395

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-39.63%
-10.00M
$9.00
-$90,000,000.00
15.24M
Mar 6
Form 3
—
0
—
—
0
Form 4
+7.37%
1.73M
—
—
25.24M
Jun 13
Form 4
+240.04%
16.59M
—
—
23.5M
Jun 6
Form 4
—
0
—
—
0
May 7
Form 3
—
0
—
—
0
Form 4
-100.00%
-6.91M
—
—
0
Apr 30
Form 3
—
0
—
—
0
No matching records found

Provention Bio, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-15.57M
—
—
0
Apr 27
Form 4
-100.00%
-426.93K
—
—
0
Apr 20 - Apr 21
Form 4
+75.33%
6.69M
$15.16
-$13.68
15.57M
Apr 14
Form 4
-25.70%
-3.22M
—
—
9.31M
Mar 31 - Apr 4
Form 4
-20.16%
-3.00M
$9.40
-$28,200,000.00
11.88M
Jan 18
Form 3
—
0
—
—
0
No matching records found

SAB Biotherapeutics, Inc. (SABS) Snapshot price: $5.54

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
4.58M
—
—
4.58M
Nov 24
Form 4/A
—
0
—
—
0
Nov 13
Form 4
—
0
—
—
0
Nov 10 - Nov 13
Form 4
—
0
—
—
0
Oct 23
Form 3
—
0
—
—
0
No matching records found